Category Archives: As I See It

Why is Genentech’s MS therapy CRM offline?

KEY TAKEAWAY: Enroll in the Genentech patient assistance (co-pay) for Ocrevus and you’re going to receive, via Fed-X, a booklet welcoming you to therapy. While I’m sure there is a marketing manager at Genentech that’s proud of this effort this CRM program could have been done online to provide better resources. Continue reading

Precision targeted ads won’t work without great creative

KEY TAKEAWAY: According to STAT news “the music streaming service Pandora is helping pharma advertisers follow users around as they listen to music on different devices throughout the day”. What in hell makes anyone think that consumers want to be interrupted with a pharma ad while listening to music?

Continue reading

Facebook is no friend to pharma

KEY TAKEAWAY: According to the Times “If I were a Facebook executive, I might feel a Frankensteinian sense of unease these days. The company has been hit with a series of scandals that have bruised its image, enraged its critics and opened up the possibility that in its quest for global dominance, Facebook may have created something it can’t fully control.”  And they want pharma to advertise more? Continue reading